Medical and Endoscopic Management of Achalasia
Article
em Ko
| WPRIM
| ID: wpr-85475
Biblioteca responsável:
WPRO
ABSTRACT
Achalasia is a rare primary esophageal motility disorder. Because its etiology is uncertain, treatment is focused on palliation of symptoms or for decreasing lower esophageal sphincter pressure. Treatment options include pharmacological, endoscopic and surgical methods. Various medications including nitrates, calcium channel blockers, and nitric oxide donors (sildenafil) are available, but their effectiveness is inconsistent. Endoscopic options include pneumatic balloon dilation, injection of botulinum toxin, temporary self-expandable metal stent placement, and peroral endoscopic myotomy. Laparoscopic or open myotomy can be a surgical option. We reviewed the treatment options focusing on medical and endoscopic management of achalasia.
Palavras-chave
Texto completo:
1
Índice:
WPRIM
Assunto principal:
Toxinas Botulínicas
/
Bloqueadores dos Canais de Cálcio
/
Transtornos da Motilidade Esofágica
/
Acalasia Esofágica
/
Stents
/
Doadores de Óxido Nítrico
/
Esfíncter Esofágico Inferior
/
Nitratos
Idioma:
Ko
Revista:
The Korean Journal of Helicobacter and Upper Gastrointestinal Research
Ano de publicação:
2014
Tipo de documento:
Article